Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells

• Published in: Naunyn-Schmiedeberg's archives of pharmacology 2023-10, Vol.396 (10), p.2405-2416
• Main Authors: Zheng, Jingna, Gong, Shiting, Wu, Gong, Zheng, Xiaohong, Li, Jincan, Nie, Juan, Liu, Yanlu, Chen, Baoyi, Liu, Yuhong, Su, Ziren, Chen, Jiannan, Li, Yucui
• Format: Article
• Language: English
• Subjects: Apoptosis; BAX protein; Bcl-2 protein; Berberine; Biomedical and Life Sciences; Biomedicine; Cell injury; Cell viability; Cytokines; Enzyme-linked immunosorbent assay; Hyperuricemia; IL-1β; Inflammation; Interleukin 18; L-Lactate dehydrogenase; Metabolic disorders; mRNA; Neurosciences; Pharmacology/Toxicology; Proteins; Pyrin protein; Renal failure; Signal transduction; siRNA; Uric acid
• ISSN: 0028-1298; 1432-1912; 1432-1912
• DOI: 10.1007/s00210-023-02451-3

Hyperuricemia (HUA) is a common chronic metabolic disease that can cause renal failure and even death in severe cases. Berberine (BBR) is an isoquinoline alkaloid derived from Phellodendri Cortex with strong antioxidant, anti-inflammatory, and anti-apoptotic properties. The purpose of this study was to investigate the protective effects of berberine (BBR) against uric acid (UA)-induced HK-2 cells and unravel their regulatory potential mechanisms. The CCK8 assay was carried out to detect cell viability. The expression levels of inflammatory factors interleukin-1β (IL-1β) and interleukin-18 (IL-18) and Lactate dehydrogenase (LDH) were measured using Enzyme-linked immunosorbent assays (ELISA). The expression of the apoptosis-related protein (cleaved-Caspase3, cleaved-Caspase9, BAX, BCL-2) was detected by western blot. The effects of BBR on the activities of the NOD-like receptor family pyrin domain containing 3 (NLRP3) and the expression of the downstream genes were determined by RT-PCR and western blot in HK-2 cells. From the data, BBR significantly reversed the up-regulation of inflammatory factors (IL-1β, IL-18) and LDH. Furthermore, BBR down-regulated protein expression of pro-apoptotic proteins BAX, cleaved caspase3 (cl-Caspase3), cleaved caspase9 (cl-Caspase9), and enhanced the expression of antiapoptotic protein BCL-2. Simultaneously, BBR inhibited the activated NLPR3 and reduced the mRNA levels of NLRP3, Caspase1, IL-18, and IL-1β. Also, BBR attenuated the expression of NLRP3 pathway-related proteins (NLRP3, ASC, Caspase1, cleaved-Caspase1, IL-18, IL-1β, and GSDMD). Furthermore, specific NLRP3-siRNA efficiently blocked UA-induced the level of inflammatory factors (IL-1β, IL-18) and LDH and further inhibited activated NLRP3 pathway. Collectively, our results suggested that BBR can alleviate cell injury induced by UA. The underlying unctionary mechanism may be through the NLRP3 signaling pathway.